preview

Research Paper On Truvada

Decent Essays

On July 16, 2012, the Food and Drug Administration (FDA) approved the use of Truvada, the first drug approved for reducing the risk of contracting an HIV infection in uninfected individuals ("FDA Approves First Drug for Reducing the Risk of Sexually Acquired HIV Infection"). Truvada is made up of two drugs, emtricitabine and tenofovir, that work by blocking an enzyme called reverse transcriptase, which HIV uses to copy its genetic material in order to reproduce. Truvada has been approved for the treatment of HIV in infected individuals for about ten years. However, scientific experiments have shown that it can be used to protect uninfected people who are at high-risk for acquiring the virus by taking the drug daily, before and after exposure (Costa-Roberts). Extensive research involving Truvada have been conducted over the years but the results have been interpreted differently among the HIV and AIDS society. While the need for a cure or vaccine for HIV is not commonly refuted, the controversy surrounding the daily use of Truvada as a preventive measure against AIDS center around effectiveness and commitment. According a major study, iPrEx, if Truvada is taken daily, it has shown to be up to 99 percent effective (Barro). However, some contemplate on whether or not this finding is more of a statistical estimate that’s based on debatable assumptions, questioning the logos. This study involved men who have sex with other men. This study discovered that men who were

Get Access